These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2006596)
1. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. Sjöberg M; Appelgren L; Einarsson S; Hultman E; Linder LE; Nitescu P; Curelaru I Acta Anaesthesiol Scand; 1991 Jan; 35(1):30-43. PubMed ID: 2006596 [TBL] [Abstract][Full Text] [Related]
2. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml. Sjöberg M; Nitescu P; Appelgren L; Curelaru I Anesthesiology; 1994 Feb; 80(2):284-97. PubMed ID: 8311311 [TBL] [Abstract][Full Text] [Related]
3. Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain. Nitescu P; Appelgren L; Linder LE; Sjöberg M; Hultman E; Curelaru I J Pain Symptom Manage; 1990 Feb; 5(1):18-26. PubMed ID: 2324557 [TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain. Nitescu P; Dahm P; Appelgren L; Curelaru I Clin J Pain; 1998 Mar; 14(1):17-28. PubMed ID: 9535310 [TBL] [Abstract][Full Text] [Related]
5. Continuous intracisternal and high cervical intrathecal bupivacaine analgesia in refractory head and neck pain. Appelgren L; Janson M; Nitescu P; Curelaru I Anesthesiology; 1996 Feb; 84(2):256-72. PubMed ID: 8602655 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: results from a prospective, crossover, double-blind, randomized study. Dahm P; Lundborg C; Janson M; Olegård C; Nitescu P Reg Anesth Pain Med; 2000; 25(5):480-7. PubMed ID: 11009233 [TBL] [Abstract][Full Text] [Related]
7. Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Sjöberg M; Karlsson PA; Nordborg C; Wallgren A; Nitescu P; Appelgren L; Linder LE; Curelaru I Anesthesiology; 1992 Feb; 76(2):173-86. PubMed ID: 1736693 [TBL] [Abstract][Full Text] [Related]
8. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Van Dongen RTM; Crul BJP; De Bock M Pain; 1993 Oct; 55(1):119-123. PubMed ID: 8278204 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps. Dahm P; Nitescu P; Appelgren L; Curelaru I Clin J Pain; 1998 Mar; 14(1):4-16. PubMed ID: 9535309 [TBL] [Abstract][Full Text] [Related]
10. Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients. Wagemans MF; van der Valk P; Spoelder EM; Zuurmond WW; de Lange JJ Acta Anaesthesiol Scand; 1997 Sep; 41(8):1033-8. PubMed ID: 9311403 [TBL] [Abstract][Full Text] [Related]
11. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients. Kiehelä L; Hamunen K; Heiskanen T Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391 [TBL] [Abstract][Full Text] [Related]
12. Sufentanil citrate and morphine/bupivacaine as alternative agents in chronic epidural infusions for intractable non-cancer pain. Hassenbusch SJ; Stanton-Hicks MD; Soukup J; Covington EC; Boland MB Neurosurgery; 1991 Jul; 29(1):76-81; discussion 81-2. PubMed ID: 1831248 [TBL] [Abstract][Full Text] [Related]
13. [Intrathecal administration of morphine and bupivacaine in the treatment of severe pain in chronic pancreatitis]. Verheijen R; Slappendel R; Jansen JB; Crul BJ; van Dongen RT Ned Tijdschr Geneeskd; 1996 Jul; 140(27):1410-2. PubMed ID: 8766685 [TBL] [Abstract][Full Text] [Related]
14. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Anderson VC; Burchiel KJ Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Intrathecal (IT) Administration of Opioid and Bupivacaine Relieved Intractable Pain in a Patient with Familial Amyloidosis Polyneuropathy: A Case Report(1). Lundborg CN; Nitescu PV; Appelgren LK; Curelaru ID Neuromodulation; 1998 Oct; 1(4):199-208. PubMed ID: 22151032 [TBL] [Abstract][Full Text] [Related]
16. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407 [TBL] [Abstract][Full Text] [Related]
17. [Intrathecal morphine therapy in children with cancer]. Meignier M; Ganansia MF; Lejus C; Testa S Cah Anesthesiol; 1992; 40(7):487-90. PubMed ID: 1477771 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal analgesia by bupivacaine is not enhanced by coadministration of morphine in patients with severe cancer-related pain: a randomized double-blind cross-over study. Reif I; Wincent A; Stiller CO Int J Clin Pharmacol Ther; 2017 Jun; 55(6):525-532. PubMed ID: 28291511 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of severe cancer pain via spinal catheters]. Andersen JS; Markers PI; Valentin N Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. Mercadante S J Pain Symptom Manage; 1994 Apr; 9(3):201-7. PubMed ID: 8014532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]